SOX10 Immunostaining in granulomatous dermatoses and benign reactive lymph nodes

Veronica Merelo Alcocer, Alexandra Flamm, Guoli Chen, Klaus Helm

Research output: Contribution to journalArticle

Abstract

Background: SOX10 immunostaining has been considered a highly sensitive and specific marker for melanoma. But there is evidence suggesting that SOX10 positive cells can be present in dermal scars. Therefore, we investigated whether non-melanocytic cell types present in chronic inflammatory processes or benign lymph nodes express SOX10. Methods: We retrospectively selected 20 benign lymph nodes and 20 cutaneous granulomatous dermatoses. SOX10, CD68, and Melan-A immunohistochemistry was performed in all cases. Results: Scattered SOX10 positivity was found in 85% of lymph nodes, specifically in subcapsular and medullary sinuses and in 85% of granulomatous dermatoses. In granulomatous dermatoses, the Melan-A stain did not label the scattered SOX10 positive cells and it was difficult to determine if CD68 was co-expressed on the SOX10 positive cells. In the lymph nodes, the SOX10 positive cells did not co-express Melan-A or CD68. Conclusions: We report SOX10 positive cells detected in granulomatous dermatoses and benign lymph nodes. In lymph nodes, SOX10 positive cells were exclusively in subcapsular and medullary sinuses. Therefore, SOX10 is an excellent stain for evaluation of metastatic melanoma with the caveat that positivity in subcapsular and medullary sinuses can be of non-melanocytic origin; the use of additional melanocytic markers is recommended in this situations.

Original languageEnglish (US)
Pages (from-to)586-590
Number of pages5
JournalJournal of Cutaneous Pathology
Volume46
Issue number8
DOIs
StatePublished - Jan 1 2019

Fingerprint

Skin Diseases
Lymph Nodes
MART-1 Antigen
Melanoma
Coloring Agents
Skin
Cicatrix
Immunohistochemistry

All Science Journal Classification (ASJC) codes

  • Pathology and Forensic Medicine
  • Histology
  • Dermatology

Cite this

@article{f0d062eae5814050ad490556f67a6a8d,
title = "SOX10 Immunostaining in granulomatous dermatoses and benign reactive lymph nodes",
abstract = "Background: SOX10 immunostaining has been considered a highly sensitive and specific marker for melanoma. But there is evidence suggesting that SOX10 positive cells can be present in dermal scars. Therefore, we investigated whether non-melanocytic cell types present in chronic inflammatory processes or benign lymph nodes express SOX10. Methods: We retrospectively selected 20 benign lymph nodes and 20 cutaneous granulomatous dermatoses. SOX10, CD68, and Melan-A immunohistochemistry was performed in all cases. Results: Scattered SOX10 positivity was found in 85{\%} of lymph nodes, specifically in subcapsular and medullary sinuses and in 85{\%} of granulomatous dermatoses. In granulomatous dermatoses, the Melan-A stain did not label the scattered SOX10 positive cells and it was difficult to determine if CD68 was co-expressed on the SOX10 positive cells. In the lymph nodes, the SOX10 positive cells did not co-express Melan-A or CD68. Conclusions: We report SOX10 positive cells detected in granulomatous dermatoses and benign lymph nodes. In lymph nodes, SOX10 positive cells were exclusively in subcapsular and medullary sinuses. Therefore, SOX10 is an excellent stain for evaluation of metastatic melanoma with the caveat that positivity in subcapsular and medullary sinuses can be of non-melanocytic origin; the use of additional melanocytic markers is recommended in this situations.",
author = "{Merelo Alcocer}, Veronica and Alexandra Flamm and Guoli Chen and Klaus Helm",
year = "2019",
month = "1",
day = "1",
doi = "10.1111/cup.13470",
language = "English (US)",
volume = "46",
pages = "586--590",
journal = "Journal of Cutaneous Pathology",
issn = "0303-6987",
publisher = "Wiley-Blackwell",
number = "8",

}

SOX10 Immunostaining in granulomatous dermatoses and benign reactive lymph nodes. / Merelo Alcocer, Veronica; Flamm, Alexandra; Chen, Guoli; Helm, Klaus.

In: Journal of Cutaneous Pathology, Vol. 46, No. 8, 01.01.2019, p. 586-590.

Research output: Contribution to journalArticle

TY - JOUR

T1 - SOX10 Immunostaining in granulomatous dermatoses and benign reactive lymph nodes

AU - Merelo Alcocer, Veronica

AU - Flamm, Alexandra

AU - Chen, Guoli

AU - Helm, Klaus

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Background: SOX10 immunostaining has been considered a highly sensitive and specific marker for melanoma. But there is evidence suggesting that SOX10 positive cells can be present in dermal scars. Therefore, we investigated whether non-melanocytic cell types present in chronic inflammatory processes or benign lymph nodes express SOX10. Methods: We retrospectively selected 20 benign lymph nodes and 20 cutaneous granulomatous dermatoses. SOX10, CD68, and Melan-A immunohistochemistry was performed in all cases. Results: Scattered SOX10 positivity was found in 85% of lymph nodes, specifically in subcapsular and medullary sinuses and in 85% of granulomatous dermatoses. In granulomatous dermatoses, the Melan-A stain did not label the scattered SOX10 positive cells and it was difficult to determine if CD68 was co-expressed on the SOX10 positive cells. In the lymph nodes, the SOX10 positive cells did not co-express Melan-A or CD68. Conclusions: We report SOX10 positive cells detected in granulomatous dermatoses and benign lymph nodes. In lymph nodes, SOX10 positive cells were exclusively in subcapsular and medullary sinuses. Therefore, SOX10 is an excellent stain for evaluation of metastatic melanoma with the caveat that positivity in subcapsular and medullary sinuses can be of non-melanocytic origin; the use of additional melanocytic markers is recommended in this situations.

AB - Background: SOX10 immunostaining has been considered a highly sensitive and specific marker for melanoma. But there is evidence suggesting that SOX10 positive cells can be present in dermal scars. Therefore, we investigated whether non-melanocytic cell types present in chronic inflammatory processes or benign lymph nodes express SOX10. Methods: We retrospectively selected 20 benign lymph nodes and 20 cutaneous granulomatous dermatoses. SOX10, CD68, and Melan-A immunohistochemistry was performed in all cases. Results: Scattered SOX10 positivity was found in 85% of lymph nodes, specifically in subcapsular and medullary sinuses and in 85% of granulomatous dermatoses. In granulomatous dermatoses, the Melan-A stain did not label the scattered SOX10 positive cells and it was difficult to determine if CD68 was co-expressed on the SOX10 positive cells. In the lymph nodes, the SOX10 positive cells did not co-express Melan-A or CD68. Conclusions: We report SOX10 positive cells detected in granulomatous dermatoses and benign lymph nodes. In lymph nodes, SOX10 positive cells were exclusively in subcapsular and medullary sinuses. Therefore, SOX10 is an excellent stain for evaluation of metastatic melanoma with the caveat that positivity in subcapsular and medullary sinuses can be of non-melanocytic origin; the use of additional melanocytic markers is recommended in this situations.

UR - http://www.scopus.com/inward/record.url?scp=85065814143&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85065814143&partnerID=8YFLogxK

U2 - 10.1111/cup.13470

DO - 10.1111/cup.13470

M3 - Article

C2 - 30957251

AN - SCOPUS:85065814143

VL - 46

SP - 586

EP - 590

JO - Journal of Cutaneous Pathology

JF - Journal of Cutaneous Pathology

SN - 0303-6987

IS - 8

ER -